CN112535811A - Diabetes therapeutic instrument - Google Patents
Diabetes therapeutic instrument Download PDFInfo
- Publication number
- CN112535811A CN112535811A CN202011459367.1A CN202011459367A CN112535811A CN 112535811 A CN112535811 A CN 112535811A CN 202011459367 A CN202011459367 A CN 202011459367A CN 112535811 A CN112535811 A CN 112535811A
- Authority
- CN
- China
- Prior art keywords
- layer
- powder
- parts
- vinyl acetate
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 36
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 106
- 239000002131 composite material Substances 0.000 claims abstract description 67
- 238000010438 heat treatment Methods 0.000 claims abstract description 49
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000004744 fabric Substances 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 20
- 230000002195 synergetic effect Effects 0.000 claims abstract description 19
- 238000009413 insulation Methods 0.000 claims abstract description 13
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 10
- 239000011888 foil Substances 0.000 claims abstract description 10
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 10
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000005855 radiation Effects 0.000 claims abstract description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 68
- 230000000844 anti-bacterial effect Effects 0.000 claims description 66
- 239000000463 material Substances 0.000 claims description 66
- 239000011148 porous material Substances 0.000 claims description 46
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 41
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 41
- 229910021532 Calcite Inorganic materials 0.000 claims description 38
- 239000002105 nanoparticle Substances 0.000 claims description 34
- 239000000377 silicon dioxide Substances 0.000 claims description 34
- 239000013078 crystal Substances 0.000 claims description 31
- 239000006185 dispersion Substances 0.000 claims description 30
- 239000011248 coating agent Substances 0.000 claims description 28
- 238000000576 coating method Methods 0.000 claims description 28
- 239000002994 raw material Substances 0.000 claims description 27
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 24
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 24
- 229910001431 copper ion Inorganic materials 0.000 claims description 24
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 21
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 21
- 239000000758 substrate Substances 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 239000002270 dispersing agent Substances 0.000 claims description 15
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 15
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 15
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 14
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 14
- 229920003081 Povidone K 30 Polymers 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000002781 deodorant agent Substances 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 239000002060 nanoflake Substances 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 230000003699 hair surface Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 51
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 208000030159 metabolic disease Diseases 0.000 abstract description 3
- 230000001877 deodorizing effect Effects 0.000 description 33
- 230000035699 permeability Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 230000006835 compression Effects 0.000 description 8
- 238000007906 compression Methods 0.000 description 8
- 229910002804 graphite Inorganic materials 0.000 description 8
- 239000010439 graphite Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000222122 Candida albicans Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 229940095731 candida albicans Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 238000005187 foaming Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- -1 graphite alkene Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000018914 glucose metabolism disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006327 polystyrene foam Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0619—Acupuncture
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
- C01F11/18—Carbonates
- C01F11/185—After-treatment, e.g. grinding, purification, conversion of crystal morphology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Abstract
The invention relates to the field of medical appliances, in particular to a diabetes therapeutic apparatus, which aims to comprise: the treatment belt comprises a first heat insulation layer, a radiation layer, a heating layer and a second heat insulation layer from top to bottom, the radiation layer comprises an aluminum foil layer and a composite layer from top to bottom, a heating wire is arranged inside the heating layer, and a graphene layer is arranged in the composite layer; the synergistic pad is arranged below the second heat-insulating layer and used for placing the traditional Chinese medicine powder bag; the inside of the cloth bag is used for placing a treatment belt and a synergistic pad; the bandage is connected with the cloth bag; the host is used for supplying power to the heating layer in a direct current manner; the graphene layer emits far infrared rays to improve blood microcirculation, strengthen blood and cell tissue metabolism and relieve diabetes symptoms caused by sugar metabolism disorder; the uniform magnetic field generated by the electrified heating wire makes the microelements in the traditional Chinese medicine beneficial to human body act on related meridian points of human body, and improves the activity of islet cells.
Description
Technical Field
The invention relates to the technical field of medical instruments, in particular to a diabetes therapeutic apparatus.
Background
A diabetes therapeutic instrument is an auxiliary therapeutic instrument for non-insulin dependent type II diabetes, and is the organic combination and application of meridian science, pharmacology and modern physical therapy theory in traditional medicine. At present, diabetes is mainly treated by diet therapy, exercise therapy, drug therapy and the like, and in recent years, a diabetes treatment instrument for treating diabetes by using a novel treatment instrument is developed. However, most of the existing diabetes therapeutic apparatuses only have single therapeutic function and poor therapeutic effect.
In addition, the composite antibacterial deodorizing material, especially the material with the characteristics of emitting infrared waves and the like, has great influence on the effect of enhancing the treatment effect of the diabetes medicine, and has the effects of preventing infection, eliminating peculiar smell and improving experience.
Ethylene-vinyl acetate copolymer (EVA) is used as a high molecular polymer material, has good plasticity, elasticity and processability, and the EVA material subjected to foaming treatment has the advantages of low density, good mechanical property, easy coloring and the like, so the EVA is often widely applied to various sole materials.
The EVA rubber-plastic product is a novel environment-friendly plastic foaming material, has the advantages of good buffering, shock resistance, heat insulation, moisture resistance, chemical corrosion resistance and the like, and is non-toxic and non-absorbent. The EVA rubber-plastic product can be processed and formed by design, has better shock resistance than the traditional foaming materials such as polystyrene (foam) and the like, meets the requirement of environmental protection, and is widely used in the fields of manufacture of technical slippers, beach sandals, health slippers and leisure slippers, case linings, children jigsaw puzzle toys, bath boards, sanitary appliance sealing gaskets, plastic floors, sound and heat insulation, car seat cushions, fishing net floats and the like.
However, the currently used antibacterial and deodorant materials have the following problems:
1. the antibacterial effect is poor;
2. the adsorption performance to peculiar smell is poor, and the deodorization effect is poor;
3. but also has the comprehensive properties of good antibacterial and deodorizing effects, excellent mechanical properties such as tensile strength and the like, good resilience, small permanent compression deformation rate and the like.
Based on the above situation, the invention provides a diabetes treatment instrument, which can effectively solve the above problems.
Disclosure of Invention
The invention aims to provide a diabetes therapeutic apparatus. The diabetes therapeutic apparatus of the invention emits far infrared rays through the graphene layer to improve blood microcirculation, strengthen blood and cell tissue metabolism, increase the vitality of cells, enable the matter exchange in vivo to be in a stable state, and alleviate the symptoms of diabetes caused by sugar metabolism disorder; the uniform and invariable magnetic field generated by the electrified heating wire enables trace elements beneficial to human bodies in the traditional Chinese medicines to act on related meridian points of the human bodies, improves the activity of islet cells and assists in treating type II diabetes;
in addition, the composite antibacterial and deodorizing material layer has good infrared wave scattering property and good antistatic effect, can greatly enhance the treatment effect of the diabetes drugs (tests show that the treatment effect of the diabetes drugs can be improved by more than 20 percent (under the same condition) by combining the composite antibacterial and deodorizing material layer of the invention for the diabetes treatment instrument), and has the effects of resisting bacteria, deodorizing, preventing infection, eliminating peculiar smell and improving experience.
In order to solve the technical problems, the technical scheme provided by the invention is as follows:
a diabetes treatment apparatus comprising:
the treatment belt comprises a first heat insulation layer, a radiation layer, a heating layer and a second heat insulation layer from top to bottom, the radiation layer comprises an aluminum foil layer and a composite layer from top to bottom, the aluminum foil layer is connected with the composite layer in an adhesive mode, a heating wire is arranged inside the heating layer, and a graphene layer is arranged in the composite layer; the synergistic pad is arranged below the second heat-insulating layer and used for placing the traditional Chinese medicine powder bag; the inside of the cloth bag is used for placing a treatment belt and a synergistic pad, and the outer side of the cloth bag is provided with a magic tape hair surface; the binding band is provided with a hook and loop fastening surface, and the hook and loop fastening surface is connected with the hook and loop fastening rough surface; and the host is used for direct current power supply of the heating layer.
Preferably, the heating layer comprises a composite antibacterial and deodorizing material layer and a heating wire which is inserted into the composite antibacterial and deodorizing material layer;
the composite antibacterial deodorizing material layer comprises a base material layer and a high-pore-volume high-air-permeability and moisture-permeable coating;
the high pore volume high air and moisture permeable coating is coated on the surface of the substrate layer;
the high-pore volume high-air-permeability and moisture-permeable coating is prepared from the following raw materials in parts by weight:
11-15.5 parts of ethylene-vinyl acetate copolymer,
40-55 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
25-32 parts of polyvinyl alcohol aqueous solution,
1-3 parts of a dispersant,
3-10 parts of composite antibacterial powder.
The composite antibacterial deodorizing material layer is prepared by selecting raw materials and optimizing the content of each raw material, so that the respective advantages are fully exerted, the raw materials complement each other and promote each other, the quality of the product is improved, and the prepared composite antibacterial deodorizing material layer has a high odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume, high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as escherichia coli, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
Preferably, the composite antibacterial powder is prepared from the following raw materials in parts by weight:
80-95 parts of pretreated crystal calcite powder,
1-5 parts of high-purity nano flake graphite powder,
1-5 parts of silver ion powder,
1-5 parts of copper ion powder.
Preferably, the preparation method of the pretreated crystalline calcite powder is as follows:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass of 0.8-1.2 times of that of the transparent crystal calcite powder, controlling the temperature to be 50-55 ℃, and stirring for reaction for 30-40 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
Preferably, the base material layer is a PET non-woven fabric, and the gram weight is 400-600 g/m 2.
Preferably, the copper ion powder is nano copper ion powder; the silver ion powder is nano silver ion powder.
Preferably, the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer with a vinyl acetate content of 35.5-37.5% and an ethylene-vinyl acetate copolymer with a vinyl acetate content of 16.5-18.5%, and the mass ratio of the ethylene-vinyl acetate copolymer to the vinyl acetate copolymer is 1: 0.22 to 0.26.
Preferably, the aqueous dispersion of large-pore hollow silica nanoparticles is 22 wt% of the aqueous dispersion of large-pore hollow silica nanoparticles.
Preferably, the particle size of the large-aperture hollow silica nanoparticles in the 22 wt% large-aperture hollow silica nanoparticle aqueous dispersion is 180 +/-5 nm, and the pore size is 30-50 nm.
Preferably, the polyvinyl alcohol aqueous solution is a 12 wt% polyvinyl alcohol aqueous solution.
Preferably, the dispersing agent is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the polyvinylpyrrolidone PVP-K30 to the DUR is 1: 0.35 to 0.38.
The heating layer is provided with convex parts at intervals from left to right, the convex parts are provided with through holes at intervals from top to bottom, and the heating wires are in serpentine arrangement and penetrate through the through holes.
Preferably, a control circuit is arranged in the host, the control circuit comprises a transformer and a rectifier, one end of the transformer is connected with 220V alternating current, the other end of the transformer is connected with one end of the rectifier, and the other end of the rectifier is electrically connected with the heating wire.
Preferably, the cloth bag is provided with an indication strip.
Preferably, the resistance of the heating wire ranges from 16 ohms to 20 ohms.
In a further improvement, the host output voltage is less than 24V.
Preferably, a zipper is arranged above the cloth bag.
Preferably, the host is a lithium battery power supply.
Compared with the prior art, the invention has the following advantages and beneficial effects:
the diabetes therapeutic apparatus of the invention emits far infrared rays through the graphene layer to improve blood microcirculation, strengthen blood and cell tissue metabolism, increase cell activity, enable substance exchange in vivo to be in a stable state, and relieve diabetes symptoms caused by glucose metabolism disorder; the uniform and invariable magnetic field generated by the electrified heating wire enables trace elements beneficial to human bodies in the traditional Chinese medicines to act on related meridian points of the human bodies, improves the activity of islet cells and assists in treating type II diabetes;
in addition, the composite antibacterial and deodorizing material layer has good infrared wave scattering property and good antistatic effect, can greatly enhance the treatment effect of the diabetes drugs (tests show that the treatment effect of the diabetes drugs can be improved by more than 20 percent (under the same condition) by combining the composite antibacterial and deodorizing material layer of the invention for the diabetes treatment instrument), and has the effects of resisting bacteria, deodorizing, preventing infection, eliminating peculiar smell and improving experience.
The composite antibacterial deodorizing material layer is prepared by selecting raw materials and optimizing the content of each raw material, so that the respective advantages are fully exerted, the raw materials complement each other and promote each other, the quality of the product is improved, and the prepared composite antibacterial deodorizing material layer has a high odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume, high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as escherichia coli, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
11-15.5 parts of ethylene-vinyl acetate copolymer in a proper proportion is added into the composite antibacterial and deodorant material layer, the ethylene-vinyl acetate copolymer is a mixture consisting of ethylene-vinyl acetate copolymer with the vinyl acetate content of 35.5-37.5% and ethylene-vinyl acetate copolymer with the vinyl acetate content of 16.5-18.5%, and the mass ratio of the ethylene-vinyl acetate copolymer to the vinyl acetate copolymer is 1: 0.22 to 0.26. Thus, the good mechanical property and the good elasticity can be ensured, and the dispersion compatibility with other raw materials in the raw material system can be ensured; thereby ensuring that the prepared compound antibacterial deodorizing material layer has large odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume and high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as escherichia coli, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
40-55 parts of large-aperture hollow silica nanoparticle aqueous dispersion with a proper proportion are added into the composite antibacterial and deodorant material layer, and the large-aperture hollow silica nanoparticle aqueous dispersion is 22 wt% of the large-aperture hollow silica nanoparticle aqueous dispersion. The particle size of the large-aperture hollow silica nanoparticles in the 22 wt% large-aperture hollow silica nanoparticle aqueous dispersion is 180 +/-5 nm, and the aperture is 30-50 nm. The raw material has large aperture and moderate particle size, and is easy to be uniformly dispersed in the raw material system so as to form good micropore effect, ensure that micro pores are densely distributed in the structure to form the effect similar to a black body, thereby ensuring that the prepared composite antibacterial deodorizing material layer has large odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume and high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as large intestine bacillus, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
25-32 parts of polyvinyl alcohol aqueous solution in a proper proportion is added into the composite antibacterial and deodorizing material layer, and the polyvinyl alcohol aqueous solution is 12 wt% of polyvinyl alcohol aqueous solution. The ethylene-vinyl acetate copolymer is mainly used for forming a good dispersion effect with the ethylene-vinyl acetate copolymer, and is a uniform gelatinized liquid after being mixed with other raw materials such as the ethylene-vinyl acetate copolymer and the like.
1-3 parts of a dispersant in a proper proportion are added into the composite antibacterial and deodorant material layer, the dispersant is a mixture of polyvinylpyrrolidone PVP-K30 and a formaldehyde-free color fixing agent DUR, and the mass ratio of the polyvinylpyrrolidone PVP to the formaldehyde-free color fixing agent DUR is 1: 0.35 to 0.38.
Through a large number of experiments, the inventor finds that the formaldehyde-free color fixing agent DUR is a high-molecular formaldehyde-free color fixing agent and has a good dispersing effect on inorganic components, and the mass ratio of the high-molecular formaldehyde-free color fixing agent DUR to the inorganic components is 1: 0.35-0.38 of polyvinylpyrrolidone PVP-K30 and a formaldehyde-free fixing agent DUR are compounded to serve as a composite dispersing agent, the two are mutually matched to play a good synergistic effect, in the raw material system, composite antibacterial powder, large-aperture hollow silica nanoparticles and the like are more easily and uniformly dispersed, and therefore the prepared composite antibacterial and deodorizing material layer is ensured to have a large odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume and high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as escherichia coli, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
The composite antibacterial and deodorant material layer is added with specially-made composite antibacterial powder in a proper proportion, and the composite antibacterial and deodorant material layer is prepared from the following raw materials in parts by weight: 80-95 parts of pretreated crystal calcite powder, 1-5 parts of high-purity nano scalene ink powder, 1-5 parts of silver ion powder and 1-5 parts of copper ion powder.
The copper ion powder is nano copper ion powder; the silver ion powder is nano silver ion powder.
The preparation method of the pretreated crystalline calcite powder comprises the following steps:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass of 0.8-1.2 times of that of the transparent crystal calcite powder, controlling the temperature to be 50-55 ℃, and stirring for reaction for 30-40 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
Therefore, the pretreated crystal calcite powder also has larger aperture, the aperture and the aperture density are uniform, the particle size of the pretreated crystal calcite powder is moderate, the pretreated crystal calcite powder is easy to disperse uniformly in the raw material system, and the pretreated crystal calcite powder is matched with large-aperture hollow silica nanoparticles to play a good synergistic effect, so that the composite antibacterial and deodorizing material layer disclosed by the invention forms a good micropore effect, ensures that micro pores are densely distributed in the structure to form an effect similar to a black body, can adsorb partial nano copper ion powder and nano silver ion powder, enables the nano copper ion powder and the nano silver ion powder to be slowly released, ensures good antibacterial effect and simultaneously improves the durability of the antibacterial effect; the high-purity nano crystalline flake graphite powder (which has strong infrared wave scattering property and can also improve the antistatic effect) and the silver ion powder and the copper ion powder are matched with each other to play a good synergistic effect, so that the antibacterial effect of the composite antibacterial and deodorizing material layer is greatly improved, and the deodorizing effect of the composite antibacterial and deodorizing material layer is further maintained; thereby ensuring that the prepared compound antibacterial deodorizing material layer has large odor reduction rate (high odor removal rate); the normal emissivity is high, which shows that micro pores are densely distributed in the structure of the material to form the effect similar to a black body, the adsorption effect on peculiar smell is good, and the material has high pore volume and high air permeability and moisture permeability; the antibacterial effect on staphylococcus aureus and various bacteria such as large intestine bacillus, candida albicans and the like is good; in addition, the mechanical properties such as tensile strength and the like are excellent, the rebound rate is high, the permanent compression deformation rate is small, and the comprehensive use performance is good.
Drawings
FIG. 1 is a schematic structural view of the present invention;
FIG. 2 is a schematic view of the internal structure of the present invention;
FIG. 3 is a schematic structural diagram of a heat generating layer according to the present invention;
FIG. 4 is a schematic structural view of a cloth bag according to the present invention;
FIG. 5 is a schematic view of the construction of the strap of the present invention;
FIG. 6 is a schematic diagram of the internal structure of the host according to the present invention;
fig. 7 is a schematic structural view of the composite antibacterial and deodorizing material layer of the present invention.
In the figure, 1-treatment belt, 11-heat insulation layer I, 12-radiation layer, 121-aluminum foil layer, 122-composite layer, 1221-graphene layer, 13-heat generation layer, 131-heating wire, 132-convex part, 133-through hole, 14-heat insulation layer II, 2-synergistic pad, 3-cloth bag, 31-magic tape hair surface, 32-indication strip, 33-zipper, 4-bandage, 41-magic tape hook surface, 5-main machine, 51-transformer and 52-rectifier;
1301-a substrate layer, 1302-a high pore volume high air and moisture permeable coating.
Detailed Description
In order that those skilled in the art will better understand the technical solutions of the present invention, the following description of the preferred embodiments of the present invention is provided in connection with specific examples, which should not be construed as limiting the present patent.
The test methods or test methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials, unless otherwise indicated, are conventionally obtained commercially or prepared by conventional methods.
The flake graphite varieties are classified according to the carbon content: if the carbon content is between 99.99 and 99.9 percent, the graphite is high-purity graphite; the carbon content is 99-94% and is high carbon graphite; the carbon content of 93-80% is medium carbon graphite; the carbon content is 75-50% and is low carbon graphite. The high-purity nano crystalline flake graphite powder is nano-scale high-purity graphite powder or nano-scale high-purity crystalline flake graphite powder.
A formaldehyde-free fixing agent DUR, which is a formaldehyde-free fixing agent DUR of Shanghai auxiliary agent factory Co., Ltd;
PVP-K30, Chinese name: polyvinylpyrrolidone, trade name: polyvinylpyrrolidone PVP-K30.
Example 1
The therapeutic belt 1 comprises a first heat-insulating layer 11, a radiation layer 12, a heating layer 13 and a second heat-insulating layer 14 from top to bottom, the radiation layer 12 comprises an aluminum foil layer 121 and a composite layer 122 from top to bottom, the aluminum foil layer 121 and the composite layer 122 are connected in an adhesive manner, the first heat-insulating layer 11 and the second heat-insulating layer 14 are integrally connected, the first heat-insulating layer 11 and the second heat-insulating layer 14 are made of heat-insulating cotton materials, a heating wire 131 is arranged inside the heating layer 13, and a graphene layer 1221 is arranged in the composite layer 122; the synergistic pad 2 is arranged below the second heat-insulating layer 14, the synergistic pad 2 is used for placing a traditional Chinese medicine powder bag, the traditional Chinese medicine bag of the synergistic pad 2 is filled with 5-10 g of angelica, 5-10 g of safflower, 5-10 g of radix cynanchi wilfordii, 5-10 g of astragalus, 5-10 g of rehmannia, 5-10 g of salvia miltiorrhiza, 5-10 g of trichosanthes root, 5-10 g of cortex lycii radicis, 5-10 g of desmodium, 5-10 g of radix stemonae and 5-10 g of angelica, and the traditional Chinese medicine powder bag is prepared by crushing, subdividing and uniformly mixing; the therapeutic belt 1 and the synergistic pad 2 are placed in the cloth bag 3, and the outer side of the cloth bag 3 is provided with a magic tape rough surface 31; the binding band 4 is provided with a hook and loop fastening surface 41, and the hook and loop fastening surface 41 is connected with the hook and loop fastening rough surface 31; and the host machine 5 is used for supplying power to the heating layer 13 through direct current.
The heating wire joint in the therapeutic belt 1 is inserted into the host 5, the synergistic pad 2 is placed in the therapeutic belt 1 close to one side of the human body, the cloth bag 3 is placed at the pancreas part of the abdomen, the other cloth bag 3 is symmetrically placed at the waist symmetrical to the pancreas, the fixation is realized through the bandage 4, and the host 5 is communicated with the power supply to start the treatment after the heating layer 13 is subjected to direct current power supply.
The host machine 5 supplies power to the heating layer 13 through direct current, the heating conducting wires 131 generate heat to hot compress and penetrate the traditional Chinese medicines into the human body, and meanwhile, the uniform and invariable-direction magnetic field generated by the electrified heating conducting wires enables trace elements which are beneficial to the human body in the traditional Chinese medicines to act on related meridian points of the human body, so that the activity of islet cells is improved, and the auxiliary treatment of type II diabetes is realized.
Be provided with one section magic subsides hook face 41 on the front of sack 3, the whole back of bandage 4 is covered with magic tape matt surface 31, and magic subsides hook face 41 makes things convenient for the dismouting with the detachable bonding form of magic tape matt surface 31 to can be according to the nimble position of adjusting sack 3 of user demand, have good practicality.
The aluminum foil layer 121 is located at the outer end of the composite layer 122, and far infrared rays far away from one side of a human body can be reflected to a certain degree by the aluminum foil in the composite layer 122, so that the reflected far infrared rays enter the human body, and the treatment effect of the far infrared rays is improved.
The heat dissipation of the heat generation of the heating wire 131 inside is reduced by the heat insulation layer 11 and the heat insulation layer 14 made of the heat insulation cotton material, and a good heating effect is kept.
The diabetes therapeutic apparatus achieves the aim of adjuvant therapy by using direct current heating wires 131, graphene layers 1221 and traditional Chinese medicine bags in a therapeutic belt to treat the hyperthermia effect, the far infrared effect, the electromagnetic field effect, the Chinese herbal medicine hot compress and osmosis effect in physiotherapy, the meridian stimulation effect of human acupuncture points, the effect of activating the air in the human body to enhance the immunity, the effect of supplementing trace elements and the like.
Example 2
Further, the heating layer 13 is provided with convex portions 132 at intervals from left to right, the convex portions 132 are provided with through holes 133 at intervals from top to bottom, and the heating wires 131 are arranged in a serpentine shape and penetrate through the through holes 133. As shown in fig. 3, the heating wires 131 are arranged in a plurality of groups of serpentine shapes on the heating layer 13, so that the whole heating layer 13 can uniformly heat, and the traditional Chinese medicine bag in the synergistic pad 2 below the heating layer 13 can uniformly conduct heat, so that the human body can receive hot compress permeation of the traditional Chinese medicine bag in a large range, and the treatment effect is improved.
Example 3
Further, a control circuit is arranged in the host 5, the control circuit includes a transformer 51 and a rectifier 52, one end of the transformer 51 is connected with 220V alternating current, the other end of the transformer 51 is connected with one end of the rectifier 52, and the other end of the rectifier 52 is electrically connected with the heating wire 131. As shown in fig. 6, 220V ac power is converted into ac 24V, 18.5V and 16V by the transformer 51, and ac 24V, 18.5V and DC16V are converted into DC (direct current) 24V, DC18.5V and DC16V by the full-bridge rectifier 52, so that the temperature of three gears, namely high, medium and low, can be obtained, and the patient can select different gears according to his or her own condition to obtain the most comfortable therapeutic effect.
Example 4
Further, an indication strip 32 is arranged on the cloth bag 3. As shown in figure 4, the indication strip 32 guides a person to operate more quickly, one side of the cloth bag 3 with the indication strip 32 is far away from the human body, namely the synergistic pad 2 in the cloth bag 3 is close to one side of the human body, and the hot compress permeation effect of the traditional Chinese medicine is better in the using process.
Example 5
Further, the resistance of the heating wire 131 ranges from 16 ohms to 20 ohms. The resistance value of the resistor is too large, the heating value is small, the hot compress infiltration effect of the traditional Chinese medicine is poor, the resistance value of the resistor is too large, the heating value is large, the skin of a human body is easily damaged due to overhigh temperature, the resistance value of the resistor can have a good effect on the hot compress infiltration of the traditional Chinese medicine within the range of 16-20 ohms, and the influence on the human body cannot be caused.
Example 6
Further, the output voltage of the host 5 is less than 24V. The human body safety voltage is not higher than 36V, the safety current is 10mA, the human body continuous contact safety voltage is 24V, and the output voltage of the host 5 is less than 24V, so that the personal safety is guaranteed.
Example 7
Further, a zipper 33 is arranged above the cloth bag 3. As shown in fig. 4, the cloth bag 3 is opened and closed by the zipper 33, and the synergistic pad 2 with the traditional Chinese medicine bag in the cloth bag 3 is conveniently replaced.
Example 8
Further, the host 5 is a lithium battery power supply. The heating layer 13 is electrically connected with a lithium battery power supply, does not need to be plugged for use, and is flexible to carry.
Example 9:
on the basis of any embodiment of 1 to 8, the composite antibacterial and deodorizing material layer comprises a substrate layer and a high-pore-volume high-air-permeable and moisture-permeable coating;
the high pore volume high air and moisture permeable coating is coated on the surface of the substrate layer;
the high-pore volume high-air-permeability and moisture-permeable coating is prepared from the following raw materials in parts by weight:
11-15.5 parts of ethylene-vinyl acetate copolymer,
40-55 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
25-32 parts of polyvinyl alcohol aqueous solution,
1-3 parts of a dispersant,
3-10 parts of composite antibacterial powder.
Preferably, the composite antibacterial powder is prepared from the following raw materials in parts by weight:
80-95 parts of pretreated crystal calcite powder,
1-5 parts of high-purity nano flake graphite powder,
1-5 parts of silver ion powder,
1-5 parts of copper ion powder.
Preferably, the preparation method of the pretreated crystalline calcite powder is as follows:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass of 0.8-1.2 times of that of the transparent crystal calcite powder, controlling the temperature to be 50-55 ℃, and stirring for reaction for 30-40 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
Preferably, the base material layer is a PET non-woven fabric, and the gram weight is 400-600 g/m 2.
Preferably, the copper ion powder is nano copper ion powder; the silver ion powder is nano silver ion powder.
Preferably, the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer with a vinyl acetate content of 35.5-37.5% and an ethylene-vinyl acetate copolymer with a vinyl acetate content of 16.5-18.5%, and the mass ratio of the ethylene-vinyl acetate copolymer to the vinyl acetate copolymer is 1: 0.22 to 0.26.
Preferably, the aqueous dispersion of large-pore hollow silica nanoparticles is 22 wt% of the aqueous dispersion of large-pore hollow silica nanoparticles.
Preferably, the particle size of the large-aperture hollow silica nanoparticles in the 22 wt% large-aperture hollow silica nanoparticle aqueous dispersion is 180 +/-5 nm, and the pore size is 30-50 nm.
Preferably, the polyvinyl alcohol aqueous solution is a 12 wt% polyvinyl alcohol aqueous solution.
Preferably, the dispersing agent is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the polyvinylpyrrolidone PVP-K30 to the DUR is 1: 0.35 to 0.38.
Example 10:
on the basis of any embodiment of 1 to 8, the composite antibacterial and deodorizing material layer comprises a substrate layer and a high-pore-volume high-air-permeable and moisture-permeable coating;
the high pore volume high air and moisture permeable coating is coated on the surface of the substrate layer;
the high-pore volume high-air-permeability and moisture-permeable coating is prepared from the following raw materials in parts by weight:
11 parts of ethylene-vinyl acetate copolymer,
40 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
25 portions of polyvinyl alcohol aqueous solution,
1 part of dispersant,
3 parts of composite antibacterial powder.
In this embodiment, the composite antibacterial powder is prepared from the following raw materials in parts by weight:
80 portions of pretreated crystal calcite powder,
1 part of high-purity nano flake graphite powder,
1 part of silver ion powder,
1 part of copper ion powder.
In this example, the preparation of the pretreated crystalline calcite powder was as follows:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass of 0.8 time, controlling the temperature to be 50 ℃, and stirring for reacting for 40 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
In the embodiment, the substrate layer is a PET non-woven fabric, and the weight of 400 g is g/m 2.
In this embodiment, the copper ion powder is a nano copper ion powder; the silver ion powder is nano silver ion powder.
In this embodiment, the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer with a vinyl acetate content of 35.5% and an ethylene-vinyl acetate copolymer with a vinyl acetate content of 16.5%, and the mass ratio of the two is 1: 0.22.
in this example, the aqueous dispersion of large-pore hollow silica nanoparticles was 22 wt% of an aqueous dispersion of large-pore hollow silica nanoparticles.
In this embodiment, the 22 wt% aqueous dispersion of large-aperture hollow silica nanoparticles has a particle size of 180 ± 5nm and a pore size of 30 to 50 nm.
In this example, the aqueous polyvinyl alcohol solution was a 12 wt% aqueous polyvinyl alcohol solution.
In this embodiment, the dispersant is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the two is 1: 0.35 to 0.38.
Example 11:
on the basis of any embodiment of 1 to 8, the composite antibacterial and deodorizing material layer comprises a substrate layer and a high-pore-volume high-air-permeable and moisture-permeable coating;
the high pore volume high air and moisture permeable coating is coated on the surface of the substrate layer;
the high-pore volume high-air-permeability and moisture-permeable coating is prepared from the following raw materials in parts by weight:
15.5 parts of ethylene-vinyl acetate copolymer,
55 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
32 parts of polyvinyl alcohol aqueous solution,
3 portions of dispersant,
10 parts of composite antibacterial powder.
In this embodiment, the composite antibacterial powder is prepared from the following raw materials in parts by weight:
95 parts of pretreated crystal calcite powder,
5 portions of high-purity nano flake graphite powder,
5 portions of silver ion powder,
5 parts of copper ion powder.
In this example, the preparation of the pretreated crystalline calcite powder was as follows:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass being 1.2 times that of the transparent crystal calcite powder, controlling the temperature to be 55 ℃, and stirring for reaction for 30 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
In the embodiment, the substrate layer is a PET non-woven fabric, and the 600 gram weight is g/m 2.
In this embodiment, the copper ion powder is a nano copper ion powder; the silver ion powder is nano silver ion powder.
In this embodiment, the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer with a vinyl acetate content of 37.5% and an ethylene-vinyl acetate copolymer with a vinyl acetate content of 18.5%, and the mass ratio of the two is 1: 0.26.
in this example, the aqueous dispersion of large-pore hollow silica nanoparticles was 22 wt% of an aqueous dispersion of large-pore hollow silica nanoparticles.
In this embodiment, the 22 wt% aqueous dispersion of large-aperture hollow silica nanoparticles has a particle size of 180 ± 5nm and a pore size of 30 to 50 nm.
In this example, the aqueous polyvinyl alcohol solution was a 12 wt% aqueous polyvinyl alcohol solution.
In this embodiment, the dispersant is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the two is 1: 0.35 to 0.38.
Example 12:
on the basis of any embodiment of 1 to 8, the composite antibacterial and deodorizing material layer comprises a substrate layer and a high-pore-volume high-air-permeable and moisture-permeable coating;
the high pore volume high air and moisture permeable coating is coated on the surface of the substrate layer;
the high-pore volume high-air-permeability and moisture-permeable coating is prepared from the following raw materials in parts by weight:
13.3 parts of ethylene-vinyl acetate copolymer,
47.5 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
28.5 parts of polyvinyl alcohol aqueous solution,
2 portions of dispersant,
6.5 parts of composite antibacterial powder.
In this embodiment, the composite antibacterial powder is prepared from the following raw materials in parts by weight:
87.5 parts of pretreated crystal calcite powder,
3 parts of high-purity nano flake graphite powder,
3 portions of silver ion powder,
2.5 parts of copper ion powder.
In this example, the preparation of the pretreated crystalline calcite powder was as follows:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass being 1 time that of the transparent crystal calcite powder, controlling the temperature to be 52.5 ℃, and stirring for reacting for 35 min; and then sequentially carrying out water washing and drying to obtain the pretreated crystal calcite powder.
In the embodiment, the substrate layer is a PET non-woven fabric, and the 500 gram weight is g/m 2.
In this embodiment, the copper ion powder is a nano copper ion powder; the silver ion powder is nano silver ion powder.
In this embodiment, the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer having a vinyl acetate content of 36.5% and an ethylene-vinyl acetate copolymer having a vinyl acetate content of 17.5%, and the mass ratio of the two is 1: 0.24.
in this example, the aqueous dispersion of large-pore hollow silica nanoparticles was 22 wt% of an aqueous dispersion of large-pore hollow silica nanoparticles.
In this embodiment, the 22 wt% aqueous dispersion of large-aperture hollow silica nanoparticles has a particle size of 180 ± 5nm and a pore size of 30 to 50 nm.
In this example, the aqueous polyvinyl alcohol solution was a 12 wt% aqueous polyvinyl alcohol solution.
In this embodiment, the dispersant is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the two is 1: 0.35 to 0.38.
The preparation method of the composite antibacterial and deodorizing material layer described in embodiments 10 to 12 of the present invention includes the following steps:
1. respectively weighing the raw materials of the high-pore volume high-air-permeability and moisture-permeable coating, and uniformly stirring and mixing to obtain a coated fabric;
2. coating the coating material on the substrate layer by adopting a scraper, controlling the coating thickness to be about 130 g per square meter, controlling the first coating thickness to be 80 +/-1 g per square meter, and drying to be semi-dry at 75 ℃; then, the second coating is carried out, the thickness of the second coating is 50 +/-1 g per square meter, and the second coating is dried at 102 ℃.
In practical application, the coating can be coated at one time according to practical situations.
The performance test of the composite antibacterial and deodorizing material layers obtained in the embodiments 10 to 12 of the invention shows that:
10cm to 10cm of the composite antibacterial and deodorizing material layer obtained in the embodiments 10 to 12 of the present invention, ammonia was used as a pollutant, and the test time was 2 hours, and the test results were: the concentration value of the odor component in the blank test is 94uL/L, while the concentration values of the odor component in the composite antibacterial and deodorizing material layer obtained in the invention from the example 10 to the example 12 are 10cm by 10cm, the concentration value of the odor component in the test is less than 0.5uL/L, the odor reduction rate is more than 99.5 percent, and the concentration value of the odor component in the test is as low as 0.35uL/L (the example 4).
The test results of the normal emissivity of the composite antibacterial and deodorant material layers obtained in the embodiments 10 to 12 of the invention are above 0.83, and the normal emissivity is as high as 0.85 (embodiment 4).
The composite antibacterial and deodorant material layers obtained in examples 10 to 12 of the present invention have a bacteriostatic rate of 99% or more against staphylococcus aureus, 96.4% or more against escherichia coli, and 95.5% or more against candida albicans
In addition, the composite antibacterial and deodorant material layers obtained in the embodiments 10 to 12 of the invention have excellent mechanical properties such as tensile strength and the like, high rebound rate, small permanent compression deformation rate and good comprehensive use performance.
The above is only a preferred embodiment of the present invention, and it should be noted that the above preferred embodiment should not be considered as limiting the present invention, and the protection scope of the present invention should be subject to the scope defined by the claims. It will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the spirit and scope of the invention, and these modifications and adaptations should be considered within the scope of the invention.
Claims (10)
1. A diabetes treatment apparatus, comprising:
the treatment belt (1) comprises a first heat insulation layer (11), a radiation layer (12), a heating layer (13) and a second heat insulation layer (14) from top to bottom, the radiation layer (12) comprises an aluminum foil layer (121) and a composite layer (122) from top to bottom, the aluminum foil layer (121) is connected with the composite layer (122) in an adhesive mode, a heating lead (131) is arranged inside the heating layer (13), and a graphene layer (1221) is arranged in the composite layer (122);
the synergistic pad (2), the synergistic pad (2) is arranged below the second heat-insulating layer (14), and the synergistic pad (2) is used for placing the traditional Chinese medicine powder bag;
the therapeutic belt (1) and the synergistic pad (2) are placed in the cloth bag (3), and the outer side of the cloth bag (3) is provided with a magic tape hair surface (31);
the binding band (4), the binding band (4) is provided with a hook-and-loop fastener surface (41), and the hook-and-loop fastener surface (41) is connected with the hook-and-loop fastener rough surface (31);
the host (5), the host (5) is used for the layer (13) that generates heat DC supply.
2. The diabetes treatment apparatus according to claim 1,
the heating layer (13) comprises a composite antibacterial and deodorant material layer (130) and a heating wire (131) which is inserted into the composite antibacterial and deodorant material layer (130);
the composite antibacterial and deodorant material layer (130) comprises a base material layer (1301) and a high-pore volume high-air-permeability and moisture-permeable coating (1302);
the high pore volume high air and moisture permeable coating (1302) is coated on the surface of the substrate layer (1301);
the high-pore volume high-air-permeability and moisture-permeable coating (1302) is prepared from the following raw materials in parts by weight:
11-15.5 parts of ethylene-vinyl acetate copolymer,
40-55 parts of large-aperture hollow silica nanoparticle aqueous dispersion,
25-32 parts of polyvinyl alcohol aqueous solution,
1-3 parts of a dispersant,
3-10 parts of composite antibacterial powder.
3. The therapeutic apparatus for diabetes mellitus as defined in claim 1, wherein said composite antibacterial powder is prepared from the following raw materials (by weight portion):
80-95 parts of pretreated crystal calcite powder,
1-5 parts of high-purity nano flake graphite powder,
1-5 parts of silver ion powder,
1-5 parts of copper ion powder.
4. The therapeutic apparatus for diabetes according to any one of claims 2 or 3, wherein the pretreated crystalline calcite powder is prepared by a process comprising:
putting transparent crystal calcite powder with the granularity of 4000-5000 meshes into a reaction container, adding 98% concentrated sulfuric acid with the mass of 0.8-1.2 times of that of the transparent crystal calcite powder, controlling the temperature to be 50-55 ℃, and stirring for reaction for 30-40 min; and then sequentially washing and drying to obtain the pretreated crystal calcite powder.
5. The diabetes treatment instrument according to claim 4, characterized in that the substrate layer (1301) is a PET non-woven fabric with a gram weight of 400-600 g/m 2;
the copper ion powder is nano copper ion powder; the silver ion powder is nano silver ion powder.
6. The diabetes therapeutic apparatus according to claim 4, wherein the ethylene-vinyl acetate copolymer is a mixture of an ethylene-vinyl acetate copolymer with a vinyl acetate content of 35.5-37.5% and an ethylene-vinyl acetate copolymer with a vinyl acetate content of 16.5-18.5%, and the mass ratio of the ethylene-vinyl acetate copolymer to the vinyl acetate copolymer is 1: 0.22 to 0.26.
7. The therapeutic apparatus for diabetes mellitus as defined in claim 4, wherein said aqueous dispersion of large-pore hollow silica nanoparticles is 22 wt% aqueous dispersion of large-pore hollow silica nanoparticles;
the particle size of the large-aperture hollow silica nanoparticles in the 22 wt% large-aperture hollow silica nanoparticle aqueous dispersion is 180 +/-5 nm, and the aperture is 30-50 nm;
the polyvinyl alcohol aqueous solution is a 12 wt% polyvinyl alcohol aqueous solution;
the dispersing agent is a mixture of polyvinylpyrrolidone PVP-K30 and formaldehyde-free fixing agent DUR, and the mass ratio of the polyvinylpyrrolidone PVP-K30 to the formaldehyde-free fixing agent DUR is 1: 0.35 to 0.38.
8. The therapeutic apparatus for diabetes mellitus as defined in claim 1, wherein the heat-generating layer (13) is provided with protrusions (132) at intervals from left to right, the protrusions (132) are provided with through holes (133) at intervals from top to bottom, and the heat-generating wires (131) are arranged in a serpentine shape to penetrate through the through holes (133).
9. The diabetes therapeutic apparatus according to claim 1, characterized in that a control circuit is arranged in the main machine (5), the control circuit comprises a transformer (51) and a rectifier (52), one end of the transformer (51) is connected with 220V alternating current, the other end of the transformer (51) is connected with one end of the rectifier (52), and the other end of the rectifier (52) is electrically connected with the heating wire (131).
10. The therapeutic apparatus for diabetes mellitus as defined in claim 1, wherein said cloth bag (3) is provided with an indicator strip (32);
the resistance range of the heating wire (131) is 16-20 ohms;
the output voltage of the host (5) is less than 24V;
a zipper (33) is arranged above the cloth bag (3);
the host (5) is a lithium battery power supply.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011459367.1A CN112535811B (en) | 2020-12-11 | 2020-12-11 | Diabetes therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011459367.1A CN112535811B (en) | 2020-12-11 | 2020-12-11 | Diabetes therapeutic instrument |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112535811A true CN112535811A (en) | 2021-03-23 |
| CN112535811B CN112535811B (en) | 2022-06-10 |
Family
ID=75018602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011459367.1A Active CN112535811B (en) | 2020-12-11 | 2020-12-11 | Diabetes therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112535811B (en) |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293278A (en) * | 2000-11-16 | 2001-05-02 | 戴彦彤 | Health-care far infrared and negative oxygen ion fabric and its preparing process |
| CN2557161Y (en) * | 2002-06-28 | 2003-06-25 | 周颖 | Traditional Chinese medicine treating bay |
| WO2005120472A1 (en) * | 2004-06-09 | 2005-12-22 | Reckitt Benckiser Healthcare (Uk) Limited | Self-heating pharmaceutical patch |
| CN2782128Y (en) * | 2005-04-19 | 2006-05-24 | 王福席 | Oxygen negative ion for imfrared Chinese medicine treatment belt |
| CN201821921U (en) * | 2010-10-16 | 2011-05-11 | 陆建益 | Intimate underwear with antibacterial and heating functions |
| CN203370102U (en) * | 2013-07-15 | 2014-01-01 | 海南泰合医疗科技有限公司 | Diabetes therapeutic apparatus |
| CN106237503A (en) * | 2016-08-17 | 2016-12-21 | 师玉国 | A kind of novel field effect therapeutic equipment lumbar vertebra special maintenance multifunctional treating torr |
| CN106345049A (en) * | 2016-09-07 | 2017-01-25 | 胡晋阳 | Device for far infrared traditional Chinese medicine plastering thermal therapy and manufacturing method of device |
| CN106758176A (en) * | 2016-12-09 | 2017-05-31 | 上海森帝诺体育用品有限公司 | A kind of antiseptic and preparation method thereof |
| US20170231813A1 (en) * | 2014-08-06 | 2017-08-17 | Handy Technology (Zhuhai) Ltd. | Self-heating thermal-insulation film and face mask and eye mask manufactured therefrom |
| CN107880524A (en) * | 2017-06-29 | 2018-04-06 | 合肥微晶材料科技有限公司 | A kind of foldable conductive electrothermal cloth of graphene nano silver wire composite and flexible and preparation method thereof |
| CN207785350U (en) * | 2017-09-14 | 2018-08-31 | 陕西荣拓智能科技有限公司 | A kind of back belt with the active fever of planar and metal profile |
| CN109730977A (en) * | 2019-01-03 | 2019-05-10 | 广东泰宝医疗科技股份有限公司 | A kind of graphene warming woman's health patch and preparation method thereof |
| CN209437474U (en) * | 2018-06-21 | 2019-09-27 | 苏州碳丰石墨烯科技有限公司 | A kind of graphene heating neck guard |
| CN110507794A (en) * | 2019-08-20 | 2019-11-29 | 广州烯旺智能穿戴技术有限责任公司 | A kind of far infrared hot compress therapy Chinese medicine package |
| CN211382146U (en) * | 2019-06-06 | 2020-09-01 | 福建合亿医疗科技有限公司 | Energy moxibustion far infrared hot compress physiotherapy bag |
| CN211750407U (en) * | 2019-10-22 | 2020-10-27 | 汪飞 | Terahertz graphene hot compress bag |
-
2020
- 2020-12-11 CN CN202011459367.1A patent/CN112535811B/en active Active
Patent Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293278A (en) * | 2000-11-16 | 2001-05-02 | 戴彦彤 | Health-care far infrared and negative oxygen ion fabric and its preparing process |
| CN2557161Y (en) * | 2002-06-28 | 2003-06-25 | 周颖 | Traditional Chinese medicine treating bay |
| WO2005120472A1 (en) * | 2004-06-09 | 2005-12-22 | Reckitt Benckiser Healthcare (Uk) Limited | Self-heating pharmaceutical patch |
| CN2782128Y (en) * | 2005-04-19 | 2006-05-24 | 王福席 | Oxygen negative ion for imfrared Chinese medicine treatment belt |
| CN201821921U (en) * | 2010-10-16 | 2011-05-11 | 陆建益 | Intimate underwear with antibacterial and heating functions |
| CN203370102U (en) * | 2013-07-15 | 2014-01-01 | 海南泰合医疗科技有限公司 | Diabetes therapeutic apparatus |
| US20170231813A1 (en) * | 2014-08-06 | 2017-08-17 | Handy Technology (Zhuhai) Ltd. | Self-heating thermal-insulation film and face mask and eye mask manufactured therefrom |
| CN106237503A (en) * | 2016-08-17 | 2016-12-21 | 师玉国 | A kind of novel field effect therapeutic equipment lumbar vertebra special maintenance multifunctional treating torr |
| CN106345049A (en) * | 2016-09-07 | 2017-01-25 | 胡晋阳 | Device for far infrared traditional Chinese medicine plastering thermal therapy and manufacturing method of device |
| CN106758176A (en) * | 2016-12-09 | 2017-05-31 | 上海森帝诺体育用品有限公司 | A kind of antiseptic and preparation method thereof |
| CN107880524A (en) * | 2017-06-29 | 2018-04-06 | 合肥微晶材料科技有限公司 | A kind of foldable conductive electrothermal cloth of graphene nano silver wire composite and flexible and preparation method thereof |
| CN207785350U (en) * | 2017-09-14 | 2018-08-31 | 陕西荣拓智能科技有限公司 | A kind of back belt with the active fever of planar and metal profile |
| CN209437474U (en) * | 2018-06-21 | 2019-09-27 | 苏州碳丰石墨烯科技有限公司 | A kind of graphene heating neck guard |
| CN109730977A (en) * | 2019-01-03 | 2019-05-10 | 广东泰宝医疗科技股份有限公司 | A kind of graphene warming woman's health patch and preparation method thereof |
| CN211382146U (en) * | 2019-06-06 | 2020-09-01 | 福建合亿医疗科技有限公司 | Energy moxibustion far infrared hot compress physiotherapy bag |
| CN110507794A (en) * | 2019-08-20 | 2019-11-29 | 广州烯旺智能穿戴技术有限责任公司 | A kind of far infrared hot compress therapy Chinese medicine package |
| CN211750407U (en) * | 2019-10-22 | 2020-10-27 | 汪飞 | Terahertz graphene hot compress bag |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112535811B (en) | 2022-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN205459738U (en) | Shank joint cover suitable for rheumatism immunity branch of academic or vocational study | |
| CN205741716U (en) | Function fabric and the clothing being made from | |
| KR101556077B1 (en) | Health belt having a warming function | |
| CN106702724A (en) | Functional fabric and production method thereof | |
| CN102702805B (en) | Electric-heating far-infrared health-protection material, preparation method and application thereof | |
| CN111330164A (en) | Novel physiotherapy sheet | |
| KR20090098932A (en) | Low Back Pain Treatment Traction Mat | |
| CN106723480A (en) | A kind of far infrared nano knee-pad | |
| CN112535811B (en) | Diabetes therapeutic instrument | |
| CN106215328A (en) | A kind of multifunction magnetic part and far infrared and anionic magnetic function health preserving equipment | |
| CN201557833U (en) | Multifunction healthcare bed mattress | |
| CN100569147C (en) | Far-infrared negative-ion magnetic health mattress | |
| CN108525132A (en) | Disposable new far infrared neck guard for health care | |
| CN104826234A (en) | Self-heating medical magnetic therapy infrared tepid paste and preparation method thereof | |
| CN103041505B (en) | Wave-energy resonance high-negative ionized meridian point waist support | |
| CN102151196A (en) | Wave energy resonance high-negative-ionizing meridian point air therapy adhesive tape | |
| CN211962592U (en) | Temperature-controllable type physiotherapy kneepad with electrical stimulation and traditional Chinese medicine transdermal administration functions | |
| CN210447654U (en) | Acupoint plaster for treating shoulder pain after stroke | |
| CN206365515U (en) | A kind of far infrared nano knee-pad | |
| CN208371006U (en) | A kind of multi-functional leg protector | |
| CN207492108U (en) | A kind of comfortable home wear of antibacterial | |
| JP2000051848A (en) | Ceramic powder, thread, cloth, molded item, water quality improver, and soil conditioner | |
| CN202961143U (en) | Meridian conditioning device capable of being fastened in taking of user and fastening belt thereof | |
| CN101333721A (en) | Multifunctional cloth | |
| CN106667796B (en) | Low-frequency physical therapy mask capable of being attached to face part based on trace biological electromagnetic stimulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |